Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 12 | $5,203,898 |
| Sells | 32 | $4,674,819 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 03 Feb 2025 19:28 | TERN | Terns Pharmaceuticals Inc | JUNG MELITA SUN | Chief Business Officer | 30 Nov 2024 | Purchase | 2,250 | 5.11 | 11,498 | D |
| 03 Feb 2025 19:25 | TERN | Terns Pharmaceuticals Inc | BURROUGHS AMY L. | Chief Executive Officer | 30 Nov 2024 | Purchase | 510 | 5.11 | 2,606 | D |
| 06 Jan 2025 19:30 | TERN | Terns Pharmaceuticals Inc | KURIAKOSE EMIL | Chief Medical Officer | 02 Jan 2025 | Sale | 4,481 | 5.7146 | 25,607 | D |
| 06 Jan 2025 19:30 | TERN | Terns Pharmaceuticals Inc | VIGNOLA MARK J. | Chief Financial Officer | 02 Jan 2025 | Sale | 8,129 | 5.7232 | 46,524 | D |
| 06 Jan 2025 19:30 | TERN | Terns Pharmaceuticals Inc | VIGNOLA MARK J. | Chief Financial Officer | 06 Jan 2025 | Sale | 9,059 | 5.7953 | 52,500 | D |
| 06 Jan 2025 19:30 | TERN | Terns Pharmaceuticals Inc | QUIGLEY JILL M. | Director | 02 Jan 2025 | Sale | 6,240 | 5.7215 | 35,702 | D |
| 06 Jan 2025 19:30 | TERN | Terns Pharmaceuticals Inc | QUIGLEY JILL M. | Director | 06 Jan 2025 | Sale | 8,760 | 5.7943 | 50,758 | D |
| 09 Dec 2024 18:04 | TERN | Terns Pharmaceuticals Inc | BURROUGHS AMY L. | Chief Executive Officer | 05 Dec 2024 | Purchase | 15,450 | 7.15 | 110,468 | D |
| 17 Sep 2024 19:48 | TERN | Terns Pharmaceuticals Inc | LU HONGBO | Director | 12 Sep 2024 | Purchase | 285,714 | 10.5 | 2,999,997 | I |
| 17 Sep 2024 19:48 | TERN | Terns Pharmaceuticals Inc | LU HONGBO | Director | 12 Sep 2024 | Purchase | 190,476 | 10.5 | 1,999,998 | I |
| 12 Sep 2024 18:10 | TERN | Terns Pharmaceuticals Inc | VIGNOLA MARK J. | Chief Financial Officer | 10 Sep 2024 | Sale | 10,000 | 11 | 110,000 | D |
| 11 Sep 2024 18:00 | TERN | Terns Pharmaceuticals Inc | QUIGLEY JILL M. | Director | 09 Sep 2024 | Sale | 17,235 | 10 | 172,350 | D |
| 05 Aug 2024 20:11 | TERN | Terns Pharmaceuticals Inc | QUIGLEY JILL M. | Director | 02 Aug 2024 | Sale | 8,857 | 7.5005 | 66,432 | D |
| 05 Aug 2024 20:11 | TERN | Terns Pharmaceuticals Inc | QUIGLEY JILL M. | Director | 01 Aug 2024 | Sale | 6,143 | 7.6751 | 47,148 | D |
| 17 Jul 2024 20:53 | TERN | Terns Pharmaceuticals Inc | GORDON CARL L | Director , 10% | 16 Jul 2024 | Sale | 623 | 10 | 6,230 | I |
| 17 Jul 2024 20:53 | TERN | Terns Pharmaceuticals Inc | GORDON CARL L | Director , 10% | 16 Jul 2024 | Sale | 556 | 10 | 5,560 | I |
| 17 Jul 2024 20:53 | TERN | Terns Pharmaceuticals Inc | GORDON CARL L | Director , 10% | 16 Jul 2024 | Sale | 4,009 | 10 | 40,090 | I |
| 17 Jul 2024 20:53 | TERN | Terns Pharmaceuticals Inc | GORDON CARL L | Director , 10% | 15 Jul 2024 | Sale | 6,142 | 10 | 61,420 | I |
| 17 Jul 2024 20:53 | TERN | Terns Pharmaceuticals Inc | GORDON CARL L | Director , 10% | 15 Jul 2024 | Sale | 39,433 | 10 | 394,330 | I |
| 17 Jul 2024 20:53 | TERN | Terns Pharmaceuticals Inc | GORDON CARL L | Director , 10% | 15 Jul 2024 | Sale | 5,401 | 10 | 54,010 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 623 | 10 | 6,230 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 556 | 10 | 5,560 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 4,009 | 10 | 40,090 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 6,142 | 10 | 61,420 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 5,401 | 10 | 54,010 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 39,433 | 10 | 394,330 | I |
| 17 Jul 2024 19:56 | TERN | Terns Pharmaceuticals Inc | QUIGLEY JILL M. | Director | 16 Jul 2024 | Sale | 400 | 10 | 4,000 | D |
| 17 Jul 2024 19:56 | TERN | Terns Pharmaceuticals Inc | QUIGLEY JILL M. | Director | 15 Jul 2024 | Sale | 14,365 | 10.0007 | 143,660 | D |
| 04 Jun 2024 18:06 | TERN | Terns Pharmaceuticals Inc | YOON SEOKHO BRYAN | COO and General Counsel | 31 May 2024 | Purchase | 4,791 | 4.44 | 21,272 | D |
| 04 Jun 2024 18:05 | TERN | Terns Pharmaceuticals Inc | VIGNOLA MARK J. | Chief Financial Officer | 31 May 2024 | Purchase | 4,791 | 4.44 | 21,272 | D |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 03 Apr 2024 | Sale | 4,149 | 6.2 | 25,724 | I |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 03 Apr 2024 | Sale | 30,047 | 6.2 | 186,291 | I |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 03 Apr 2024 | Sale | 103,870 | 6.2 | 643,994 | I |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 02 Apr 2024 | Sale | 3,050 | 6.65 | 20,282 | I |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 02 Apr 2024 | Sale | 22,084 | 6.65 | 146,859 | I |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 02 Apr 2024 | Sale | 76,346 | 6.65 | 507,701 | I |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 01 Apr 2024 | Sale | 5,451 | 6.99 | 38,102 | I |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 01 Apr 2024 | Sale | 39,411 | 6.99 | 275,483 | I |
| 03 Apr 2024 20:47 | TERN | Terns Pharmaceuticals Inc | VIVO OPPORTUNITY, LLC | 10% | 01 Apr 2024 | Sale | 136,255 | 6.99 | 952,422 | I |
| 04 Dec 2023 18:03 | TERN | Terns Pharmaceuticals Inc | YOON SEOKHO BRYAN | COO and General Counsel | 30 Nov 2023 | Purchase | 743 | 3.78 | 2,809 | D |
| 04 Dec 2023 18:03 | TERN | Terns Pharmaceuticals Inc | VIGNOLA MARK J. | Chief Financial Officer | 30 Nov 2023 | Purchase | 743 | 3.78 | 2,809 | D |
| 02 Jun 2023 17:03 | TERN | Terns Pharmaceuticals Inc | VIGNOLA MARK J. | Chief Financial Officer | 31 May 2023 | Purchase | 9,997 | 1.41 | 14,096 | D |
| 02 Jun 2023 17:03 | TERN | Terns Pharmaceuticals Inc | YOON SEOKHO BRYAN | COO and General Counsel | 31 May 2023 | Purchase | 9,997 | 1.41 | 14,096 | D |
| 02 Jun 2023 17:03 | TERN | Terns Pharmaceuticals Inc | SUNDARAM SENTHIL VEL | Chief Executive Officer | 31 May 2023 | Purchase | 2,111 | 1.41 | 2,977 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)